Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics

Hyperprogressive disease (HPD) is an adverse outcome of immunotherapy consisting of an acceleration of tumor growth associated with prompt clinical deterioration. The definitions based on radiological evaluation present important technical limitations. No biomarkers have been identified yet. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Arasanz, Hugo, Zuazo, Miren, Bocanegra, Ana, Gato, María, Martínez-Aguillo, Maite, Morilla, Idoia, Fernández, Gonzalo, Hernández, Berta, López, Paúl, Alberdi, Nerea, Hernández, Carlos, Chocarro, Luisa, Teijeira, Lucía, Vera, Ruth, Kochan, Grazyna, Escors, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073153/
https://www.ncbi.nlm.nih.gov/pubmed/32033028
http://dx.doi.org/10.3390/cancers12020344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073153/
https://www.ncbi.nlm.nih.gov/pubmed/32033028
http://dx.doi.org/10.3390/cancers12020344

Ejemplares similares